CDC Notes Rise in Kava Exposure and Kava-Kratom Co-Use

The Centers for Disease Control and Prevention has reported a steady increase in kava exposure since 2011, with a notable rise in 2025. The agency also highlighted a growing trend of combined kava and kratom use. This development is identified as a public health concern due to potential adverse interactions between the substances.

Context

Kava is a beverage made from the root of the kava plant, traditionally used for its calming effects. Kratom, derived from a Southeast Asian tree, is often used for pain relief and mood enhancement. The CDC's report indicates a steady increase in kava exposure since 2011, with a marked rise in 2025, highlighting a shift in consumption patterns.

Why it matters

The rise in kava exposure and its combination with kratom raises significant public health concerns. Both substances can have psychoactive effects, and their co-use may lead to unexpected health risks. Increased awareness is crucial for consumers and healthcare providers to mitigate potential adverse effects.

Implications

Individuals using kava and kratom may face heightened health risks due to potential interactions. Healthcare providers may need to be more vigilant in assessing patients' substance use. The findings could influence regulatory discussions around the sale and marketing of these substances.

What to watch

Health agencies may issue new guidelines or warnings regarding kava and kratom use. Monitoring of adverse health effects related to these substances could increase. Public health campaigns may be initiated to educate consumers about the risks of combining these substances.